Why Pulmonx Corporation’s (LUNG) Stock Is Up 8.18%
As of Thursday, November 19, Pulmonx Corporation’s LUNG share price has surged by 8.18%, which has investors questioning if this is right time to sell.Jenna Brashear
| SECTOR | INDUSTRY |
| Health Care | Health Care Equipment & Supplies |
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
Jenna Brashear
Jenna Brashear
Tudor Pop
Michael Rose
Tudor Pop
| Share Statistics | LUNG | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $112.6 | $363.7 | 24% |
|
| Shares Out (Mil) | 43.2 | 41.1 | 44% |
|
| Institutional Ownership | 90.2% | 82.7% | 58% |
|
| Float (Mil) | 37.9 | 36.7 | 40% |
|
| Beta | 0.17 | 0.89 | 11% |
|
| Avg Daily Volume (000s) | 741 | 326 | 64% |
|
| Price Change (52-week) |
87.3% | 54.6% | 95% |
|
| Growth | LUNG | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | 22.6% | 11.8% | 84% |
|
| Net Income (5yr) | (10.9%) | (5.8%) | 28% |
|
| EPS (5yr) | 16.0% | 10.6% | 60 |
|
| Dividends (5yr) | 0.0% | 0.0% | 0% |
|
| Cash Flow (5yr) | (14.9%) | (15.6%) | 53% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | 6 | 6 | 6 | |
| Current EPS | ($0.217) | ($0.970) | ($0.912) | |
| Month Ago EPS | ($0.218) | ($1.044) | ($0.942) | |
| # Rev Up | 1 | 0 | 0 | |
| # Rev Down | 1 | 1 | 1 | |
| Three Months Ago EPS | ($0.218) | ($1.044) | ($0.942) | |
| Year/Year Chg | 11.9% | (26.9%) | (44.4%) | |
| Financials | LUNG | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $89 | $123 | 25% |
|
| Net Income (TTM) (Mil) | ($43) | ($9) | 17% |
|
| EPS (TTM) | ($1.007) | ($0.300) | 21% |
|
| Operating Cash Flow (TTM) (Mil) | ($26) | ($1) | 14% |
|
| Net Cash Flow (TTM) (Mil) | ($24) | $2 | 27% |
|
| Long-Term Debt (Q1) (Mil) | $55 | $21 | 39% |
|
| Enterprise Value (Q1) (Mil) | $128 | $381 | 24% |
|
| Valuation | LUNG | Industry Median |
Percentile (All Stocks) |
|
| P/B | 3.27 | 2.41 | 73% |
|
| P/E | na | 25.5 | na |
|
| Dividend Yield | 0.0% | 0.0% | 0% |
|
| PEG (5yr hist) | na | 1.3 | na |
|
| Ratios | LUNG | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 77.4% | 59.5% | 87% |
|
| Net Margin | (47.9%) | (5.0%) | 12% |
|
| ROA | (34.2%) | (10.4%) | 15% |
|
| ROE | (90.3%) | (8.4%) | 10% |
|
| Liabilities to Assets | 69.0% | 45.8% | 65% |
|
| F-Score | 4 | 4 | 33% |
|
Pulmonx Corporation did not pass any screens on 11/20/2026.
Price and market data provided by QuoteMedia and delayed a minimum of 15 minutes unless otherwise indicated. Fundamental data provided by AAII's Stock Investor Pro and S&P Global Market Intelligence and are updated through the previous trading day.
Ⓒ 2026 American Association of Individual Investors